Keyphrases
GPI-anchored Protein (GPI-AP)
100%
N-acetyltransferase 2 (NAT2)
51%
Trypanosoma Brucei
48%
Biosynthetic Pathway
46%
GlcNAc
38%
Myo-inositol
34%
Inositol
32%
Substrate Analog
28%
Substrate Specificity
22%
Membrane Anchor
21%
African Sleeping Sickness
19%
Mannosyltransferase
18%
Amino
17%
Phosphatidylinositol
16%
Glucopyranosyl
16%
Cell-free System
15%
Phosphate
12%
N-acetylation
11%
Suicide Substrate
10%
Synthetic Substrate
10%
Hydroxamic Acid
9%
OH Groups
9%
Sn-1
9%
Protozoan Parasites
9%
African Trypanosomes
9%
Drug Target
9%
Human Cells
8%
Zinc-binding Group
8%
Octyl
7%
Bloodstream Forms
7%
Zinc Metalloprotease
7%
Causative Agents
7%
Human HeLa Cells
6%
Metalloenzymes
6%
Eukaryotes
6%
HeLa
6%
Trypanosome
6%
β-glycerophosphate
6%
HeLa Cells
6%
Cell Permeable
6%
Specific Inhibition
6%
Octadecyl
5%
Mannosylation
5%
Leishmania Major
5%
Therapeutic Target
5%
Monosaccharides
5%
Natural Substrate
5%
Metal-binding Groups
5%
Group Targets
5%
Epoxide Ring Opening
5%
Biochemistry, Genetics and Molecular Biology
Anabolism
72%
Glycosylphosphatidylinositol
65%
Acyltransferase
30%
N-Acetyltransferase
30%
Inositol
29%
Substrate Analog
21%
Enzyme
20%
Membrane Anchor
20%
Trypanosoma Brucei
17%
Enzyme Specificity
11%
Phosphatidylinositol
10%
Cell-Free System
10%
Metalloenzyme
10%
Mannosyltransferase
9%
Trypanosoma
7%
Protozoon
7%
Precursor
7%
Eukaryote
7%
Glycoconjugate
6%
Lipid
5%
Plasmodium falciparum
5%
Aspergillus fumigatus
5%
Arabinose
5%
Glucose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Glycosylphosphatidylinositol
63%
Acyltransferase
41%
Inositol
37%
Trypanosoma Brucei
31%
Substrate Specificity
17%
Mannosyltransferase
15%
African Trypanosomiasis
14%
Phosphatidylinositol
11%
Protozoon
10%
Hydroxamic Acid
8%
Acetic Acid Derivative
7%
Trypanosoma
6%
Glycoconjugate
5%
Plasmodium falciparum
5%
Leishmania Major
5%
